India’s Unique Wound Dressing That Stops Bleeding in Minutes Gets FDA Nod!

In a first, an Indian-make haemostatic dressing that stops haemorrhage from actively bleeding vessels within minutes of administering through natural clotting has been approved by US FDA (Federal Drugs Administration).

Extensively used by the Indian Armed forces, Border Security Force, National Security Guard, and other Paramilitary forces as part of their defence kit, Axiostat is an instant first-aid dressing which has earned the rare distinction of being the first Indian wound care product to receive FDA clearance on Wednesday.

Similar Story

Can Your Innovation Change Lives? Apply for ‘Quiet Innovators’ Contest; Total Prizes of Rs 4 Lakh

Attention, changemakers! Need a platform for your innovation? The ‘Quiet Innovators’ contest by The Better India and Shiv Nadar Foundation aims to empower you and help you scale up your impact.

Read more >

A flagship patented product of Bengaluru-based Axio Biosolutions, what makes Axiostat unlike any other haemostatic bandage is its incorporation of chitosan, a saccharine biopolymer obtained from the hard outer skeleton of shellfish that can stop bleeding in less than four minutes.

This feature helps in saving the lives of wounded soldiers posted at the border and conflict zones, where even a minute is crucial to their survival when compared to traditional compression methods lasting up to 30 minutes. The dressing can be easily removed through the thorough washing of wound with saline water.

Besides the military, Axiostat is also used by hospitals, ambulance services, industries and relief aid and has prevented fatality owing to traumatic injuries in battlefields, hospitals, and road accidents across the world.

You may also like: India’s First Completely Indigenous Vaccine Gets WHO Pre-Qualification!

“This is a validation of the performance, safety and efficacy of Axiostat in bleeding control. This is a ‘made in India’ product for the global market,” said Bioengineer Leo Mavely, who is the founder and CEO of Axio Biosolutions, to The New Indian Express.

Founded in 2008 by Mavely to develop a biopolymer-based wound care products, Axiostat is currently being put to use in 12 other countries, besides India.

Though Axiostat already had the European CE marking for medical accreditation, it can now be extensively marketed across the United States as over-the-counter (OTC) product to control bleeding with FDA clearance.

You can look more about Axio Biosolutions here.

Like this story? Or have something to share?
Write to us: contact@thebetterindia.com
Connect with us on Facebook and Twitter.
NEW: Click here to get positive news on WhatsApp!